CYTOKINETICS INC — Director's Dealing 2024

Dec 17, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-12-16

Reporting Person: WIERENGA WENDALL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-16	Common Stock	M	742	$7.37	Acquired	25301	Direct
2024-12-16	Common Stock	S	742	$48.61	Disposed	24559	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-12-16	Non-Qualified Stock Option (Right to Buy)	$7.37	M	742	Disposed	2025-01-02	Common Stock (742)	Direct

Footnotes

F1: This option shall vest and become exercisable as to 5,936 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2016.